Cargando…
Targeting metabolism: A potential strategy for hematological cancer therapy
Most hematological cancer-related relapses and deaths are caused by metastasis; thus, the importance of this process as a target of therapy should be considered. Hematological cancer is a type of cancer in which metabolism plays an essential role in progression. Therefore, we are required to block f...
Autores principales: | Tang, Xue, Chen, Fen, Xie, Li-Chun, Liu, Si-Xi, Mai, Hui-Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082716/ https://www.ncbi.nlm.nih.gov/pubmed/35647127 http://dx.doi.org/10.12998/wjcc.v10.i10.2990 |
Ejemplares similares
-
Reprogramming lipid metabolism as potential strategy for hematological malignancy therapy
por: Zhang, Leqiang, et al.
Publicado: (2022) -
Emerging Metabolic Targets in the Therapy of Hematological Malignancies
por: Leni, Zaira, et al.
Publicado: (2013) -
The presence of wild type p53 in hematological cancers improves the efficacy of combinational therapy targeting metabolism
por: Allende-Vega, Nerea, et al.
Publicado: (2015) -
Molecular-Targeted Therapies for Hematologic Malignancies
por: Bunting, Kevin D., et al.
Publicado: (2012) -
Cardiotoxicity of Novel Targeted Hematological Therapies
por: Giudice, Valentina, et al.
Publicado: (2020)